electrochemical generation of a nonheme oxoiron(IV) complex

The complex [Fe(IV)O(N4Py)]2+ (N4Py = N,N-bis(2-pyridylmethyl)-N-bis(2-pyridyl)methylamine) has been prepared by bulk electrolysis in aqueous CH3CN and CH2Cl2, and its redox properties characterized. Bulk chronocoulometry and spectropotentiometry experiments in CH3CN show that [Fe(II)(N4Py)(NCCH3)]2+ can be oxidized quantitatively to its iron(III) derivative at an applied potential of +0.71 V vs ferrocene and then to the oxoiron(IV) complex (in the presence of added water) at potentials above +1.3 V. The E1/2 value for the Fe(IV/III) couple has been estimated to be +0.90 V from spectropotentiometric titrations in CH3CN and cyclic voltammetric measurements in CH2Cl2.     

Unexpected kinetic complexity in the formation of a nonheme oxoiron(IV) complex

The stoichiometric formation of [FeIV(O)(TPA)(NCMe)]2+ (TPA = tris(2-pyridylmethyl)amine) from the reaction of [FeII(TPA)(NCMe)2]2+ with 1 equiv. peracetic acid exhibits more kinetic complexity than might be expected from the simple stoichiometry. A multiple-pathway mechanism with an FeIV-peracetic acid species, [(TPA)FeIV(O)((H)O3CR)]2+/+, as the primary oxidant is proposed.     

Regioselectivity of aliphatic versus aromatic hydroxylation by a nonheme iron(II)-superoxo complex

Many enzymes in nature utilize molecular oxygen on an iron center for the catalysis of substrate hydroxylation. In recent years, great progress has been made in understanding the function and properties of iron(IV)-oxo complexes; however, little is known about the reactivity of iron(II)-superoxo intermediates in substrate activation. It has been proposed recently that iron(II)-superoxo intermediates take part as hydrogen abstraction species in the catalytic cycles of nonheme iron enzymes. To gain insight into oxygen atom transfer reactions by the nonheme iron(II)-superoxo species, we performed a density functional theory study on the aliphatic and aromatic hydroxylation reactions using a biomimetic model complex. The calculations show that nonheme iron(II)-superoxo complexes can be considered as effective oxidants in hydrogen atom abstraction reactions, for which we find a low barrier of 14.7 kcal mol(-1) on the sextet spin state surface. On the other hand, electrophilic reactions, such as aromatic hydroxylation, encounter much higher (>20 kcal mol(-1)) barrier heights and therefore are unlikely to proceed. A thermodynamic analysis puts our barrier heights into a larger context of previous studies using nonheme iron(IV)-oxo oxidants and predicts the activity of enzymatic iron(II)-superoxo intermediates.     

A high-spin iron(IV)-oxo complex supported by a trigonal nonheme pyrrolide platform

We report the generation and characterization of a new high-spin iron(IV)-oxo complex supported by a trigonal nonheme pyrrolide platform. Oxygen-atom transfer to [(tpa(Mes))Fe(II)](-) (tpa(Ar) = tris(5-arylpyrrol-2-ylmethyl)amine) in acetonitrile solution affords the Fe(III)-alkoxide product [(tpa(Mes2MesO))Fe(III)](-) resulting from intramolecular C-H oxidation with no observable ferryl intermediates. In contrast, treatment of the phenyl derivative [(tpa(Ph))Fe(II)](-) with trimethylamine N-oxide in acetonitrile solution produces the iron(IV)-oxo complex [(tpa(Ph))Fe(IV)(O)](-) that has been characterized by a suite of techniques, including mass spectrometry as well as UV-vis, FTIR, M?ssbauer, XAS, and parallel-mode EPR spectroscopies. Mass spectral, FTIR, and optical absorption studies provide signatures for the iron-oxo chromophore, and M?ssbauer and XAS measurements establish the presence of an Fe(IV) center. Moreover, the Fe(IV)-oxo species gives parallel-mode EPR features indicative of a high-spin, S = 2 system. Preliminary reactivity studies show that the high-spin ferryl tpa(Ph) complex is capable of mediating intermolecular C-H oxidation as well as oxygen-atom transfer chemistry.     

Bioinspired nonheme iron complex that triggers mitochondrial apoptotic signalling pathway specifically for colorectal cancer cells

The activation of dioxygen is the keystone of all forms of aerobic life. Many biological functions rely on the redox versatility of metal ions to perform reductive activation-mediated processes entailing dioxygen and its partially reduced species including superoxide, hydrogen peroxide, and hydroxyl radicals, also known as reactive oxygen species (ROS). In biomimetic chemistry, a number of synthetic approaches have sought to design, synthesize and characterize reactive intermediates such as the metal-superoxo, -peroxo, and -oxo species, which are commonly found as key intermediates in the enzymatic catalytic cycle. However, the use of these designed complexes and their corresponding intermediates as potential candidates for cancer therapeutics has scarcely been endeavored. In this context, a series of biomimetic first-row transition metal complexes bearing a picolylamine-based water-soluble ligand, [M(HN₃O₂)]²⁺ (M = Mn²⁺, Fe²⁺, Co²⁺, Cu²⁺; HN₃O₂ = 2-(2-(bis(pyridin-2-ylmethyl)amino)ethoxy)ethanol) were synthesized and characterized by various spectroscopic methods including X-ray crystallography and their dioxygen and ROS activation reactivity were evaluated in situ and in vitro. It turned out that among these metal complexes, the iron complex, [Fe(HN₃O₂)(H₂O)]²⁺, was capable of activating dioxygen and hydrogen peroxide and produced the ROS species (e.g., hydroxyl radical). Upon the incubation of these complexes with different cancer cells, such as cervical, breast, and colorectal cancer cells (MDA-MB-231, AU565, SK-BR-3, HeLa S3, HT-29, and HCT116 cells), only the iron complex triggered cellular apoptosis specifically for colorectal cancer cells; the other metal complexes show negligible anti-proliferative activity. More importantly, the biomimetic complexes were harmless to normal cells and produced less ROS therein. The use of immunocytochemistry combined with western blot analysis strongly supported that apoptosis occurred via the intrinsic mitochondrial pathway; in the intracellular network, [Fe(HN₃O₂)(H₂O)]²⁺ resulted in (i) the activation and/or production of ROS species, (ii) the induction of intracellular impaired redox balance, and (iii) the promotion of the mitochondrial apoptotic signaling pathway in colorectal cancer cells. The results have implications for developing novel biomimetic complexes in cancer treatments and for designing potent candidates with cancer-specific antitumor activity.

A water-soluble iron complex that produces hydroxyl radical species triggers colorectal cancer cell death via the mitochondrial apoptotic pathway.     

Dioxygen activation and catalytic aerobic oxidation by a mononuclear nonheme iron(II) complex

We have used dioxygen, not artificial oxidants such as peracids, iodosylarenes, and hydroperoxides, in the generation of a mononuclear nonheme oxoiron(IV) complex, [Fe(IV)(TMC)(O)]2+ (TMC = 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane), from its corresponding Fe(II) complex, [Fe(TMC)(CF3SO3)2]. The formation of oxoiron(IV) species by activating dioxygen was markedly dependent on iron(II) complexes and solvents, and this observation was interpreted with the electronic effect of iron(II) complexes on dioxygen activation to form oxoiron(IV) species. A catalytic aerobic oxidation of organic substrates was demonstrated in the presence of the [Fe(TMC)]2+ complex. By carrying out 18O-labeled water experiment, we were able to conclude that the oxidation of organic substrates was mediated by an oxoiron(IV) intermediate, not by a radical type of autoxidation process.     

Formation, stability, and reactivity of a mononuclear nonheme oxoiron(IV) complex in aqueous solution

A mononuclear nonheme oxoiron(IV) complex bearing a pentadentate N5 ligand was prepared in aqueous solution; the pH dependence of its stability and reactivities was reported along with the mechanistic details of sulfide oxidation by the oxoiron(IV) species.     

Ligand topology effect on the reactivity of a mononuclear nonheme iron(IV)-oxo complex in oxygenation reactions

Mononuclear nonheme iron(IV)-oxo complexes with two different topologies, cis-α-[Fe(IV)(O)(BQCN)](2+) and cis-β-[Fe(IV)(O)(BQCN)](2+), were synthesized and characterized with various spectroscopic methods. The effect of ligand topology on the reactivities of nonheme iron(IV)-oxo complexes was investigated in C-H bond activation and oxygen atom-transfer reactions; cis-α-[Fe(IV)(O)(BQCN)](2+) was more reactive than cis-β-[Fe(IV)(O)(BQCN)](2+) in the oxidation reactions. The reactivity difference between the cis-α and cis-β isomers of [Fe(IV)(O)(BQCN)](2+) was rationalized with the Fe(IV/III) redox potentials of the iron(IV)-oxo complexes: the Fe(IV/III) redox potential of the cis-α isomer was 0.11 V higher than that of the cis-β isomer.     

Efficient aldehyde olefination reactions catalyzed by an iron porphyrin complex in an ionic liquid

The commercially available complex Fe(TPP)Cl is an active and highly (E)-selective catalyst for the olefination of a variety of aldehydes in the presence of PPh₃ and diazoacetate in the ionic liquid (bmim)(PF₆). Dependent on the reactivity of the applied aldehyde, the reaction can be carried out at a reaction temperature of 50-80 °C. After 0.5-24 h quantitative olefin yields are reached with a broad variety of different aldehydes. Due to the application of an ionic liquid as reaction medium the products can be easily removed from the catalyst by a simple extraction and the catalyst is conveniently reusable without significant activity loss. Spectroscopic investigations indicate that the reaction mechanism includes the quantitative formation of a phosphorus ylide, which then reacts further in a Wittig reaction under formation of an olefin.     

Mononuclear zinc(II) complex with 2,3,5,6-tetra(2-pyridyl)pyrazine

Complex [Zn(Tppz)Cl₂] (I), where Tppz = 2,3,5,6-tetrakis(2-pyridyl)pyrazine, has been synthesized and characterized by elemental analyses, IR, ¹H NMR, cyclic voltammetry, and electronic spectral studies. Solid state structures of the complex have been determined by single-crystal X-ray crystallography. The structural determination shows that the mononuclear complex I is a 1D coordination polymer. Also an ORTEP drawing of complex I shows that the coordination geometry around the Zn(II) center is slightly distorted from regular square-based pyramidal. Crystal data for I: triclinic, spase group P $ \bar 1 $ , a = 10.171(2), b = 10.3550(13), c = 12.239 (2) Å, α = 64.839(9)°, β = 85.736(8)°, γ = 77.842(10)°, V = 1140.3(4) ų, Z = 2.     

Coupling of an aldehyde or ketone to pyridine mediated by a tungsten imido complex

The reactivity of W(NPh)(o-(Me3SiN)2C6H4)(py)2 and W(NPh)(o-(Me3SiN)2C6H4)(pic)2 (py=pyridine; pic=4-picoline) with unsaturated substrates has been investigated. Treatment of W(NPh)(o-(Me3SiN)2C6H4)(py)2 with diphenylacetylene or 2,3-dimethyl-1,3-butadiene generates W(NPh)(o-(Me3SiN)2C6H4)(eta2-PhCCPh) and W(NPh)(o-(Me3SiN)2C6H4)(eta4-CH2=C(Me)C(Me)=CH2), respectively, while the addition of ethylene to W(NPh)(o-(Me3SiN)2C6H4)(py)2 generates the known metallacycle W(NPh)(o-(Me3SiN)2C6H4)(CH2CH2CH2CH2). The addition of 2 equiv of acetone to W(NPh)(o-(Me3SiN)2C6H4)(pic)2 provides the azaoxymetallacycle W(NPh)(o-(Me3SiN)2C6H4)(OCH(Me)2)(OC(Me)2-o-C5H3N-p-Me), the result of acetone insertion into the ortho C-H bond of picoline. Similarily, the addition of 2 equiv of RC(O)H [R=Ph, tBu] to W(NPh)(o-(Me3SiN)2C6H4)(py)2 generates W(NPh)(o-(Me3SiN)2C6H4)(OCH2R)(OCHR-o-C5H4N) [R=Ph, tBu,]. In contrast, reaction between W(NPh)(o-(Me3SiN)2C6H4)(py)2 and 2-pyridine carboxaldehyde yields the diolate W(NPh)(o-(Me3SiN)2C6H4)(OCH(C5H4N)CH(C5H4N)O). The synthesis of W(NPh)(o-(Me3SiN)2C6H4)(PMe3)(py)(eta2-OC(H)C6H4-p-Me), formed by the addition of p-tolualdehyde to a mixture of W(NPh)(o-(Me3SiN)2C6H4)(py)2 and PMe3, suggests that an eta2-aldehyde intermediate is involved in the formation of the azaoxymetallacycle, while the isolation of W(NPh)(o-(Me3SiN)2C6H4)(Cl)(OC(Me)(CMe3)-o-C5H4N), formed by the reaction of pinacolone with W(NPh)(o-(Me3SiN)2C6H4)(py)2, in the presence of adventitious CH2Cl2, suggests that the reaction proceeds via the hydride W(NPh)(o-(Me3SiN)2C6H4)(H)(OC(Me)(CMe3)-o-C5H4N).     

Sulfoxidation on a SiO2-supported Ru complex using O2/aldehyde system

A site-isolated SiO(2)-supported Ru-monomer complex, whose structure was characterized by means of solid-state NMR, XPS, UV/vis, and Ru K-edge EXAFS, was found to be efficient for sulfoxidation using an O(2)/aldehyde system. Significant enhancement of sulfoxidation rates was observed on the SiO(2)-supported Ru complex for various sulfide derivatives.     

Artificial metalloprotease with active site comprising aldehyde group and Cu(II)cyclen complex

To design artificial proteases that cleave peptide backbones of a wide range of proteins at selected sites, artificial active sites comprising the Cu(II) complex of cyclen (Cu(II)Cyc) and aldehyde group were synthesized on a cross-linked polystyrene. The aldehyde group was employed as the binding site in view of its ability of reversible formation of imine bonds with epsilon-amino groups of Lys residues exposed on the surface of proteins and Cu(II)Cyc as the catalytic group for peptide hydrolysis. The two polymeric artificial metalloproteases synthesized in the present study cleaved all of the protein substrates examined (myoglobin, gamma-globulin, bovine serum albumin, human serum albumin, lysozyme, and ovalbumin), manifesting saturation kinetic behavior. At 50 degrees C and pH 9.0 or 9.5, K(m) was (1.3-22) x 10(-)(4) M, comparable to those of natural proteases, and k(cat) was (6.0-25) x 10(-)(4) s(-)(1), corresponding to half-lives of 4.6-19 min. Intermediacy of the imine complexes formed between the aldehyde group of the catalyst and the epsilon-amino groups of Lys residues of the substrates was confirmed by the trapping experiment with NaB(OAc)(3)H. MALDI-TOF MS of the proteolytic reaction mixtures revealed formation of various cleavage products. Structures of some of the cleavage products were determined by using carboxypeptidase A and trypsin. Among various cleavage sites thus identified, Gln(91)-Ser(92) and Ala(94)-Thr(95) were the major initial cleavage sites in the degradation of myoglobin by the two catalysts. The selective cleavage of Gln(91)-Ser(92) and Ala(94)-Thr(95) was attributed to general acid assistance in peptide cleavage by Tyr(146) located in proximity to the two peptide bonds. Broad substrate selectivity, high cleavage-site selectivity, and high proteolytic rate are achieved, therefore, by positioning the aldehyde group in proximity to Cu(II)Cyc attached to a cross-linked polystyrene.     

Stepwise nitrosylation of the nonheme iron site in an engineered azurin and a molecular basis for nitric oxide signaling mediated by nonheme iron proteins

Mononitrosyl and dinitrosyl iron species, such as {FeNO}⁷, {FeNO}⁸ and {Fe(NO)₂}⁹, have been proposed to play pivotal roles in the nitrosylation processes of nonheme iron centers in biological systems. Despite their importance, it has been difficult to capture and characterize them in the same scaffold of either native enzymes or their synthetic analogs due to the distinct structural requirements of the three species, using redox reagents compatible with biomolecules under physiological conditions. Here, we report the realization of stepwise nitrosylation of a mononuclear nonheme iron site in an engineered azurin under such conditions. Through tuning the number of nitric oxide equivalents and reaction time, controlled formation of {FeNO}⁷ and {Fe(NO)₂}⁹ species was achieved, and the elusive {FeNO}⁸ species was inferred by EPR spectroscopy and observed by Mössbauer spectroscopy, with complemental evidence for the conversion of {FeNO}⁷ to {Fe(NO)₂}⁹ species by UV-Vis, resonance Raman and FT-IR spectroscopies. The entire pathway of the nitrosylation process, Fe(ii) → {FeNO}⁷ → {FeNO}⁸ → {Fe(NO)₂}⁹, has been elucidated within the same protein scaffold based on spectroscopic characterization and DFT calculations. These results not only enhance the understanding of the dinitrosyl iron complex formation process, but also shed light on the physiological roles of nitric oxide signaling mediated by nonheme iron proteins.

Stepwise nitrosylation from Fe(ii) to {FeNO}⁷, {FeNO}⁸ and then to {Fe(NO)₂}⁹ is reported for the first time in the same protein scaffold, providing deeper understanding of the detailed mechanism of dinitrosyl iron complex formation.     

Selective inactivation of serine proteases by nonheme iron complexes

Oxidative inactivation of the serine proteases trypsin and chymotrypsin by nonheme iron complexes is described. The nonheme ligands N4Py (1) and derivative 3CG-N4Py (2), which contains a pendant guanidinium group, were used as ligands for iron. Ferryl (Fe(IV)O) species derived from these ligands, [Fe(IV)(O)(N4Py)](2+) (7) and [Fe(IV)(O)(3CG-N4Py)](3+) (8), inactivate trypsin and chymotrypsin by the oxidation of amino acid side chains. Ferryl 8 is most effective with chymotrypsin (IC(50) value of 26 μM for 8 vs 119 μM for 7). IC(50) values of 71 and 54 μM were obtained for trypsin with 7 and 8, respectively. Amino acid analysis confirmed that residues cysteine, tyrosine, and tryptophan are oxidized under these conditions. Trypsin is inactivated preferentially over chymotrypsin under catalytic conditions, where the enzyme was pulsed with H(2)O(2) in the presence of ferrous complexes [Fe(II)(OH(2))(N4Py)](2+)(5) and [Fe(II)(Cl)(3CG-N4Py)](2+) (6). Control experiments support the action of a unique oxidant, other than ferryls or hydroxyl radicals, under these conditions, where tyrosine residues are targeted selectively.